Literature DB >> 6457870

Modulation of Ia-like antigen expression and antigen-presenting activity of human monocytes by endotoxin and zymosan A.

A W Yem, M J Parmely.   

Abstract

The environmental agents E. coli endotoxin and zymosan A modulated antigen-specific T cell proliferation in vitro, assessed by 3H-TdR uptake. In the continual presence of these agents, human mononuclear leukocyte responses to the antigens tuberculin PPD, Candida albicans, and mumps were significantly reduced. Treatment of adherent cell-depleted T cells with the agents did not affect their subsequent reactivity to soluble antigens in the presence of normal M phi. However, cultures consisting of pretreated M phi, normal T cells, and soluble antigen gave responses that were only 7 to 38% of control values, indicating that the function of the antigen-presenting cell, not the T cell, was inhibited. This effect was observed only when treatment with endotoxin or zymosan A preceded antigen stimulation by at least 24 hr, suggesting that a gradual inhibition of antigen presentation had occurred. When various ratios of normal antigen-pulsed and agent-treated M phi were cultured with normal T cells, antigen-specific responses were not significantly different from control cultures; this indicated that M phi-mediated suppression was not involved. It did not appear that the inhibition was due to enhanced antigen degradation by the treated M phi because responses were not reconstituted in the presence of excess antigen. After endotoxin or zymosan A treatment of the M phi population the proportion of Ia+ cells was reduced significantly, and surface expression of Ia antigen correlated with the ability of the cell population to present antigens to immune T cells. This suggested that endotoxin and zymosan A induce a loss of surface Ia antigen on antigen-presenting cells that inhibits immune T cell activation.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6457870

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  12 in total

Review 1.  Regulatory properties of mononuclear phagocytes reflect specialized functional status.

Authors:  M J Parmely
Journal:  Surv Immunol Res       Date:  1984

2.  1,25-Dihydroxyvitamin D3 down-regulation of HLA-DR on human peripheral blood monocytes.

Authors:  N Tokuda; N Mizuki; M Kasahara; R B Levy
Journal:  Immunology       Date:  1992-02       Impact factor: 7.397

3.  Defective macrophage antigen presentation following haemorrhage is associated with the loss of MHC class II (Ia) antigens.

Authors:  A Ayala; M M Perrin; I H Chaudry
Journal:  Immunology       Date:  1990-05       Impact factor: 7.397

4.  Class II major histocompatibility complex antigen expression on peripheral blood monocytes in patients with inflammatory bowel disease.

Authors:  K R Gardiner; A D Crockard; M I Halliday; B J Rowlands
Journal:  Gut       Date:  1994-04       Impact factor: 23.059

5.  Regulation of human peripheral blood monocyte DR antigen expression in vitro by lymphokines and recombinant interferons.

Authors:  M B Sztein; P S Steeg; H M Johnson; J J Oppenheim
Journal:  J Clin Invest       Date:  1984-02       Impact factor: 14.808

6.  Relative efficacy of human monocytes and dendritic cells as accessory cells for T cell replication.

Authors:  W C Van Voorhis; J Valinsky; E Hoffman; J Luban; L S Hair; R M Steinman
Journal:  J Exp Med       Date:  1983-07-01       Impact factor: 14.307

7.  Upregulation and induction of surface antigens with special reference to MHC class II expression in microglia in postnatal rat brain following intravenous or intraperitoneal injections of lipopolysaccharide.

Authors:  J Xu; E A Ling
Journal:  J Anat       Date:  1994-04       Impact factor: 2.610

8.  Induction of mouse monocyte Ia expression by a mesangial cell-derived product.

Authors:  W Yamashita; Y J Liu; B S Ooi
Journal:  Clin Exp Immunol       Date:  1993-02       Impact factor: 4.330

9.  T cell subsets in leprosy lesions: in situ characterization using monoclonal antibodies.

Authors:  R B Narayanan; L K Bhutani; A K Sharma; I Nath
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

10.  In situ localization of interferons in psoriatic lesions.

Authors:  J K Livden; R Nilsen; J R Bjerke; R Matre
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.